Today's Brokerage Rating: Leidos Holdings, Inc. (LDOS), Thermo Fisher Scientific Inc. (TMO)

Mae Love
December 7, 2017

Stock to Watch: Thermo Fisher Scientific Inc.

Returns and Valuations for Thermo Fisher Scientific Inc. The overall volume in the last trading session was 1.16 million shares. The institutional investor owned 49,387 shares of the medical research company's stock after purchasing an additional 554 shares during the quarter. Thermo Fisher Scientific Inc has a 1-year low of $139.88 and a 1-year high of $201.20. (TMO) has risen 15.57% since December 6, 2016 and is uptrending. It has underperformed by 1.13% the S&P500. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company's stock worth $7,841,000 after buying an additional 12,910 shares in the last quarter. The stock was trading at a distance of -9.32% from its 52-week highs and stands 30.43% away from its 52-week lows. About 5,000 shares traded or 64.15% up from the average. DiamondRock Hospitality Company (NYSE:DRH) has risen 33.29% since December 7, 2016 and is uptrending. It has outperformed by 27.93% the S&P500.

Investors sentiment increased to 1.06 in Q2 2017. Its down 0.70, from 1.33 in 2017Q1. It dropped, as 43 investors sold TMO shares while 415 reduced holdings.

At the session level, shares of Inc.(NYSE:CARS) moved 1.75% from the open. Commonwealth Equity Ser Incorporated stated it has 0.04% of its portfolio in Thermo Fisher Scientific Inc.

A number of analysts have issued reports on TMO shares.

VANGUARD GROUP INC raised its stake in Inc. (NYSE:TMO). Colony Limited Liability holds 0.05% or 3,693 shares in its portfolio.

Gus Malzahn agrees to 'broad outlines' of new deal with Auburn
According to reports , Guz Malzahn will continue to coach the Auburn Tigers after signing an extension. "Our goal today was to come out and compete", second-year Georgia coach Kirby Smart said.

Joaquin Phoenix unleashes hell in You Were Never Really Here trailer
The cast also features Judith Roberts , John Doman , Alex Manette , Dante Pereira-Olsen, and Alessandro Nivola . Here's what we had to say about the film when we caught it at the BFI London Film Festival back in October.

Incyte Corporation (INCY) Director Sells 28507 Shares of Stock
The biopharmaceutical company reported $0.17 EPS for the quarter, topping the Zacks' consensus estimate of $0.06 by $0.11. Ladenburg Thalmann Financial Services Inc. raised its stake in shares of Incyte by 1.7% in the fourth quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. (NYSE:TMO) for 5,043 shares. (NYSE:TMO). Pinnacle Assoc Limited reported 32,379 shares stake. Massmutual Commerce Fsb Adv reported 0% in Thermo Fisher Scientific Inc. (NYSE:TMO) earned "Hold" rating by Jefferies on Tuesday, June 6. Gamco Et Al has invested 0% in BIOLASE, Inc. Stockholders of record on Friday, December 15th will be issued a dividend of $0.15 per share. Highland Capital Ltd Co reported 0.55% stake. Moreover, Caxton Associate Ltd Partnership has 0% invested in Thermo Fisher Scientific Inc. Whalerock Point Prtnrs Ltd Liability Company holds 0.18% of its portfolio in Thermo Fisher Scientific Inc.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, October 25th. Following the transaction, the chief financial officer now owns 40,290 shares of the company's stock, valued at approximately $6,394,425.90. TMO's profit will be $1.07B for 17.23 P/E if the $2.67 EPS becomes a reality.

Leidos Holdings, Inc. (LDOS) have shown a high EPS growth of 23.10% in the last 5 years and has earnings decline of -28.60% yoy. One analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Therefore 94% are positive. Cowen reissued an "outperform" rating and set a $220.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Sunday, September 10th. The rating was maintained by Jefferies on Tuesday, August 22 with "Hold". The company was maintained on Thursday, July 23 by Mizuho. Thermo Fisher Scientific has a consensus rating of "Buy" and a consensus price target of $205.21. The firm has "Americas Conviction Buy List" rating given on Tuesday, December 8 by Goldman Sachs. They set a "buy" rating and a $225.00 price objective on the stock. As per Thursday, October 26, the company rating was maintained by Deutsche Bank. The company was downgraded on Thursday, February 9 by Raymond James.

TMO has been the topic of several research analyst reports. Parallax Volatility Advisers L P, California-based fund reported 4,331 shares. The change in volume gives a closer look at the stock with a percentage rate of 0.23%. Heritage Wealth Advsr stated it has 1,208 shares. It increased, as 13 investors sold DiamondRock Hospitality Company shares while 55 reduced holdings.

So, most importantly, where are shares headed from here? Corporate insiders own 0.49% of the company's stock. Parkside Finance State Bank & accumulated 247 shares or 0.02% of the stock. Manufacturers Life Insur The has invested 0% in DiamondRock Hospitality Company (NYSE:DRH). (NYSE:TMO). Factory Mutual Ins holds 449,200 shares or 0.91% of its portfolio. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. After a recent check, it is observed that the insiders for the firm now own 0.20% shares. 790.40 million shares or 0.23% less from 792.22 million shares in 2017Q1 were reported. (NASDAQ:PCLN) for 3,356 shares. 14 were accumulated by Delta Asset Mngmt Limited Company Tn. Out of 13 Wall Street analysts rating Twitter, 2 give it "Buy", 6 "Sell" rating, while 5 recommend "Hold". This may also include tracking analyst opinions and following what the big money institutions are buying or selling. Therefore 11% are positive. Thermo Fisher Scientific has $226 highest and $140 lowest target. The Ing Groep Nv holds 8,340 shares with $1.46 million value, down from 31,225 last quarter. The company was upgraded on Wednesday, February 8 by BTIG Research. The stock has "Overweight" rating by JP Morgan on Wednesday, November 1. On Monday, September 25 the stock rating was maintained by Barclays Capital with "Buy". Citigroup downgraded the shares of TWTR in report on Friday, February 10 to "Sell" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by

Discuss This Article